Inhibitors of Akt activity
US7655649B2 · kind B2 · utility
19Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2005 |
| Grant date | Feb 2, 2010 |
| Priority date | — |
| Expiry date | Aug 13, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds which contain substituted pyridazines and pyrimidines moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.